NO995945L - Nye forbindelser - Google Patents

Nye forbindelser

Info

Publication number
NO995945L
NO995945L NO995945A NO995945A NO995945L NO 995945 L NO995945 L NO 995945L NO 995945 A NO995945 A NO 995945A NO 995945 A NO995945 A NO 995945A NO 995945 L NO995945 L NO 995945L
Authority
NO
Norway
Prior art keywords
new connections
connections
new
disclosed
pharmaceutical compositions
Prior art date
Application number
NO995945A
Other languages
English (en)
Norwegian (no)
Other versions
NO995945D0 (no
Inventor
David Philip Elder
Ahmad Khalaf Al Deeb A Ghazawi
Padma Meneaud
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9914601.1A external-priority patent/GB9914601D0/en
Priority claimed from GBGB9914709.2A external-priority patent/GB9914709D0/en
Priority claimed from GBGB9927501.8A external-priority patent/GB9927501D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO995945D0 publication Critical patent/NO995945D0/no
Publication of NO995945L publication Critical patent/NO995945L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO995945A 1999-06-22 1999-12-03 Nye forbindelser NO995945L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9914601.1A GB9914601D0 (en) 1999-06-22 1999-06-22 Composition
GBGB9914709.2A GB9914709D0 (en) 1999-06-23 1999-06-23 Composition
GBGB9927501.8A GB9927501D0 (en) 1999-11-19 1999-11-19 Composition

Publications (2)

Publication Number Publication Date
NO995945D0 NO995945D0 (no) 1999-12-03
NO995945L true NO995945L (no) 2000-12-27

Family

ID=27269749

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995945A NO995945L (no) 1999-06-22 1999-12-03 Nye forbindelser

Country Status (21)

Country Link
EP (1) EP1064936A1 (fi)
AT (1) AT3722U1 (fi)
AU (2) AU727000B3 (fi)
BE (2) BE1013166A6 (fi)
CA (1) CA2291542A1 (fi)
CH (1) CH690024A5 (fi)
DE (2) DE29921300U1 (fi)
DK (2) DK199900435U3 (fi)
ES (1) ES2159260B1 (fi)
FI (2) FI19992609A (fi)
FR (1) FR2795327A1 (fi)
GB (1) GB2351233A (fi)
GR (1) GR1003490B (fi)
IE (2) IES991108A2 (fi)
IT (1) ITMI992549A1 (fi)
LU (1) LU90483B1 (fi)
NL (2) NL1013749C2 (fi)
NO (1) NO995945L (fi)
PT (1) PT102384A (fi)
SE (1) SE9904404L (fi)
WO (1) WO2000078291A1 (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
EP1313474A2 (en) * 2000-08-28 2003-05-28 Synthon B.V. Paroxetine compositions and processes for making the same
AU2001284322A1 (en) 2000-08-29 2002-03-13 Ranbaxy Laboratories Limited Synthesis of n,n-dimethyl-3-(4-methyl) benzoyl propionamide, a key intermediate of zolpidem
DE20100529U1 (de) * 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat
CA2361882A1 (en) * 2001-10-19 2003-04-19 Bernard Charles Sherman Liquid for oral administration comprising paroxetine
EP1469829B1 (en) 2002-02-01 2016-01-27 Bend Research, Inc Immediate release dosage forms containing solid drug dispersions
WO2005010002A1 (en) * 2003-07-31 2005-02-03 Ranbaxy Laboratories Limited Process for the synthesis of zolpidem
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
CN105963273A (zh) * 2016-05-02 2016-09-28 杭州富阳伟文环保科技有限公司 甲磺酸帕罗西汀胶囊及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR930702000A (ko) * 1990-11-24 1993-09-08 데이빗 로버츠 노년기 치매, 식용항진, 편두통, 또는 식용불량의 치료를 위한 파로세틴의 사용
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation
GB9605828D0 (en) * 1996-03-20 1996-05-22 Smithkline Beecham Plc Treatment method
SI0994872T1 (fi) * 1997-06-10 2001-08-31 Synthon Bv
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.

Also Published As

Publication number Publication date
GB2351233A (en) 2000-12-27
AT3722U1 (de) 2000-07-25
ITMI992549A1 (it) 2001-06-03
BE1012806A3 (fr) 2001-03-06
ES2159260B1 (es) 2002-05-01
SE9904404D0 (sv) 1999-12-03
IE991107A1 (en) 2001-05-30
DE19958228A1 (de) 2000-12-28
DK199900435U3 (da) 2000-02-11
NL1013749C2 (nl) 2001-01-08
DE29921300U1 (de) 2000-02-10
DK199901730A (da) 2000-12-23
FI19992609A (fi) 2000-12-22
WO2000078291A1 (en) 2000-12-28
ES2159260A1 (es) 2001-09-16
AU1573100A (en) 2001-01-09
IES991108A2 (en) 2001-04-04
GR1003490B (el) 2000-11-30
ITMI992549A0 (it) 1999-12-03
CH690024A5 (fr) 2000-03-31
FR2795327A1 (fr) 2000-12-29
EP1064936A1 (en) 2001-01-03
SE9904404L (sv) 2000-12-23
FI4488U1 (fi) 2000-07-20
FIU990494U0 (fi) 1999-12-03
LU90483B1 (fr) 2001-01-31
NO995945D0 (no) 1999-12-03
NL1013750C1 (nl) 2000-12-28
AU727000B3 (en) 2000-11-30
PT102384A (pt) 2000-12-29
CA2291542A1 (en) 2000-12-22
BE1013166A6 (fr) 2001-10-02
GB9928673D0 (en) 2000-02-02

Similar Documents

Publication Publication Date Title
NO20063393L (no) Farmasoytiske preparater
DK200000390U1 (da) Farmaceutiske præparater til oral indgivelse, der omfatter paroxetin-methansulfonat.
DK1311285T3 (da) Flydende farmaceutisk præparat, som omfatter et erythropoietinderivat
NO20021116L (no) Nye sammensetninger
DK1175402T3 (da) Piperidinderivater, der er nyttige som CCR5-antagonister
NO20042373L (no) Nye 1,2,4-tiadiazoliumderivater som melanokortinreseptormodulatorer
ITTO20000779A0 (it) Composizioni farmaceutiche.
NO20052306D0 (no) Dispergerbare farmasoytiske blandinger.
NO20014518L (no) Nye forbindelser
DK1202994T3 (da) Nye forbindelser
NO20042807L (no) Farmasoytiske sammensetninger som innbefatter aktive vitamin D forbindelser
NO20021239D0 (no) Pteridinoner som kinase-inhibitorer
NO20022886D0 (no) Nye lipopeptider som antibakterielle midler
NO20042372L (no) Nye 1,2,4-tiadiazolderivater som melanokortinreseptormodulatorer
DK1460066T3 (da) Piperazinforbindelse som tachykinin-inhibitorer
NO20022888D0 (no) Nye lipopeptider som antibakterielle midler
NO20021436D0 (no) Nye forbindelser
NO20042739L (no) Farmasoytiske sammensetninger av 5,6,14-triazatetracyklo(10.3.1.0(2,11).0(4,9))-heksadeca-2(11)3,5,7,9-pentan
NO20015383L (no) Nye forbindelser
NO20015074L (no) Nye sammensetninger
NO20063293L (no) Farmasoytiske forbindelser
NO995945L (no) Nye forbindelser
NO20044448L (no) Nye forbindelser
NO20032614L (no) Farmasöytisk sammensetning som har forbedret absorberbarhet
IS5730A (is) Setin tíazóló-pýridazín afleiða, lyfjasamsetningar gerðar úr henni

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application